Get notified when VNRX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Covenant Violation (new) — Company violated minimum market capitalization covenant on convertible debt, requiring lender waiver to avoid acceleration.
NYSE: VNRX VOLITIONRX LTD 8-K

VolitionRx breaches debt covenant, faces $990K penalty and more dilutive conversion terms

Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read

Key Changes

  • high

    Company violated minimum market capitalization requirement on $9.9M in convertible notes, triggering automatic 10% penalty ($990K) on outstanding principal and requiring lender waiver to avoid immediate repayment.

  • high

    Lender Lind can now convert debt to shares at more favorable terms: the lower of existing conversion price or 90% of the average of three lowest trading prices over prior 20 days, significantly increasing dilution risk.

  • high

    Waiver prevents immediate default and acceleration of $9.9M debt ($7.5M from May 2025 note, $2.4M from January 2026 note), but company's declining market cap suggests ongoing covenant compliance challenges.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.

Partner

Trade VNRX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · May 24, 2026 · How we verify